The SIRT1 activator SRT‐1720 significantly reduced the BUN, Scr, KIM‐1, NGAL levels in LPS‐induced AKI, and its effect on kidneys was also supported by histological assessment (Figure 5A‐F). This evidence concerns the gene LCN2 and acute kidney injury.